![Response to subcutaneous octreotide in a cohort of patients with bronchorrhoea | European Respiratory Society Response to subcutaneous octreotide in a cohort of patients with bronchorrhoea | European Respiratory Society](https://erj.ersjournals.com/content/erj/46/suppl_59/PA3964/F1.large.jpg)
Response to subcutaneous octreotide in a cohort of patients with bronchorrhoea | European Respiratory Society
![Cancers | Free Full-Text | Effect of Octreotide Long-Acting Release on Tregs and MDSC Cells in Neuroendocrine Tumour Patients: A Pivotal Prospective Study | HTML Cancers | Free Full-Text | Effect of Octreotide Long-Acting Release on Tregs and MDSC Cells in Neuroendocrine Tumour Patients: A Pivotal Prospective Study | HTML](https://www.mdpi.com/cancers/cancers-12-02422/article_deploy/html/images/cancers-12-02422-g008.png)
Cancers | Free Full-Text | Effect of Octreotide Long-Acting Release on Tregs and MDSC Cells in Neuroendocrine Tumour Patients: A Pivotal Prospective Study | HTML
![Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data | Gut Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data | Gut](https://gut.bmj.com/content/gutjnl/49/suppl_4/iv11/F5.large.jpg)
Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data | Gut
![Octreotide inhibits the proliferation of gastric cancer cells through P300-HAT activity and the interaction of ZAC and P300 Octreotide inhibits the proliferation of gastric cancer cells through P300-HAT activity and the interaction of ZAC and P300](https://www.spandidos-publications.com/article_images/or/37/4/OR-37-04-2041-g17.jpg)
Octreotide inhibits the proliferation of gastric cancer cells through P300-HAT activity and the interaction of ZAC and P300
![Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms in: Endocrine-Related Cancer Volume 15 Issue 3 (2008) Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms in: Endocrine-Related Cancer Volume 15 Issue 3 (2008)](https://erc.bioscientifica.com/view/journals/erc/15/3/images/large/701fig3.jpeg)
Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms in: Endocrine-Related Cancer Volume 15 Issue 3 (2008)
![Somatostatin analogs: does pharmacology impact antitumor efficacy?: Trends in Endocrinology & Metabolism Somatostatin analogs: does pharmacology impact antitumor efficacy?: Trends in Endocrinology & Metabolism](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2011038766/2033498926/gr2.jpg)
Somatostatin analogs: does pharmacology impact antitumor efficacy?: Trends in Endocrinology & Metabolism
![Octreotide, a Somatostatin Analogue, Mediates Its Antiproliferative Action in Pituitary Tumor Cells by Altering Phosphatidylinositol 3-Kinase Signaling and Inducing Zac1 Expression | Cancer Research Octreotide, a Somatostatin Analogue, Mediates Its Antiproliferative Action in Pituitary Tumor Cells by Altering Phosphatidylinositol 3-Kinase Signaling and Inducing Zac1 Expression | Cancer Research](https://cancerres.aacrjournals.org/content/canres/66/3/1576/F6.large.jpg)
Octreotide, a Somatostatin Analogue, Mediates Its Antiproliferative Action in Pituitary Tumor Cells by Altering Phosphatidylinositol 3-Kinase Signaling and Inducing Zac1 Expression | Cancer Research
![Somatostatin receptor-targeted organometallic iridium( iii ) complexes as novel theranostic agents - Chemical Communications (RSC Publishing) DOI:10.1039/C7CC01946G Somatostatin receptor-targeted organometallic iridium( iii ) complexes as novel theranostic agents - Chemical Communications (RSC Publishing) DOI:10.1039/C7CC01946G](https://pubs.rsc.org/image/article/2017/CC/c7cc01946g/c7cc01946g-s1_hi-res.gif)